Thiolated chitosans

Journal of Drug Delivery Science and Technology

Volumn 20, Issue 1, 2010, Pages 63-69

  Sakloetsakun, D ^a   Bernkop Schnurch A ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

In situ gelling properties; Micro nanoparticles; Mucoadhesive properties; Permeation enhancing effects; Thiolated chitosans

Indexed keywords

CALCITONIN; CHITOSAN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INSULIN; NANOPARTICLE; SALCATONIN;

CARBOHYDRATE SYNTHESIS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; HUMAN; IN VIVO STUDY; INFUSION PUMP; MUCOADHESION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSTEOPOROSIS; PAGET BONE DISEASE; REVIEW; VIRAL GENE DELIVERY SYSTEM;

EID: 76749171314     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(10)50007-8     Document Type: Review

References (66)

1. Hejazi R., Amiji M. - Chitosan-based gastrointestinal delivery systems. - J. Control Release, 89, 151-165, 2003.
2. Chandy T., Sharma C. - Chitosan as a biomaterial. - Biomater. Artif. Cells Artif. Organs, 18, 1-24, 1990.
3. Felt O., Buri P., Gurny R. - Chitosan: a unique polysaccharide for drug delivery. - Drug Dev. Ind. Pharm., 24, 979-993, 1998.
4. Agnihotri S., Mallikarjuna N., Aminabhavi T. - Recent advances on chitosan-based micro- and nanoparticles in drug delivery. - J. Control Release, 100, 5-28, 2004.
5. Werle M., Takeuchi H., Bernkop-Schnürch A.- Modified chitosans for oral drug delivery. - J. Pharm. Sci., 98, 1643-1656, 2008.
6. Bernkop-Schnürch A. - Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. - Int. J. Pharm., 194, 1-13, 2000.
7. Borchard G. - Chitosans for gene delivery. - Adv. Drug. Deliv. Rev., 52, 145-150, 2001.
8. Bernkop-Schnürch A., Krauland A., Valenta C. -Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate. - J. Drug Target, 6, 207-214, 1998.
9. Thanou M., Florea B., Langemeÿer M., Verhoef J., Junginger H. - N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats). - Pharm. Res., 17, 27-31, 2000.
10. Thanou M., Nihot M., Jansen M., Verhoef J., Junginger H. -Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo. - J. Pharm. Sci., 90, 38-46, 2001.
11. Baumann H., Paust V. - Concepts for improved regioselective placement of O-sulfo, N-sulfo, N-acetyl, and N-carboxymethyl groups in chitosan derivatives. - Carbohydr. Res., 331, 43-57, 2001.
12. Bernkop-Schnürch A., Brandt U., Clausen A. - Synthese und in vitro Evaluierung von Chiotsan-Cystein Konjugaten. - Scientia Pharmazeutica, 67, 197-208, 1999.
13. Kafedjiiski K., Krauland A.H., Hoffer M.H., Bernkop-Schnurch A. - Synthesis and in vitro evaluation of a novel thiolated chitosan. - Biomaterials, 26, 819-826, 2005.
14. Bernkop-Schnürch A., Hornof M., Zoidl T. -Thiolated polymersthiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. - Int. J. Pharm., 260, 229-237, 2003.
15. Schmitz T., Hombach J., Bernkop-Schnürch A. - Chitosan-N-acetyl cysteine conjugates: in vitro evaluation of permeation enhancing and P-glycoprotein inhibiting properties. - Drug Deliv., 15, 245-252, 2008.
16. Kafedjiiski K., Föger F., Werle M., Bernkop-Schnürch A. - Synthesis and in vitro evaluation of a novel chitosan-glutathione conjugate. - Pharm. Res., 22, 1480-1488, 2005.
17. Millotti G., Samberger C, Fröhlich E., Bernkop-Schnürch A. -Chitosan-graft-6mercaptonicotinic acid: synthesis, characterization, and biocompatibility. - Biomacromolecules, 10, 3023-3027, 2009.
18. Wilson J.M., Bayer R.J., Hupe D. - Structure-reactivity correlations for the thiol-disulfide interchange reaction. - J. Am. Chem. Soc, 99, 7922-7926, 1977.
19. Bernkop-Schnürch A., Schwarz V., Steininger S. -Polymers with thiol groups: a new generation of mucoadhesive polymers? -Pharm. Res., 16, 876-881, 1999.
20. Dodou D., Breedveld P., Wieringa P. - Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. - Eur. J. Pharm. Biopharm., 60, 1-16, 2005.
21. Leitner V.M., Walker G.F., Bernkop-Schnurch A.-Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. - Eur. J. Pharm. Biopharm., 56, 207-214, 2003.
22. th Annual Meeting and Exposition of the Controlled Release Society, July 12-16, 2008, Controlled Release Society Inc., p 894.
23. Madara J., Stafford J., Dharmsathaphorn K., Carlson S. -Structural analysis of a human intestinal epithelial cell line. - Gastroenterology, 92, 1133-1145, 1987.
24. Gupta H.,Jain S., Mathur R., Mishra P., Mishra A.K., Velpandian T. - Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. - Drug Deliv., 14, 507-515, 2007.
25. Hou Q., Chau D.Y., Pratoomsoot C, Tighe P.J., Dua H.S., Shakesheff K.M., Rose F.R. - In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine. - J. Pharm. Sci, 97, 3972-3980, 2008.
26. Edsman K., Carlfors J., Petersson R.- Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. - Eur. J. Pharm. Sci., 6, 105-112, 1998.
27. Ishihara M., Obara K., Nakamura S., Fujita M., Masuoka K., Kanatani Y., Takase B., Hattori H., Morimoto Y., Maehara T., Kikuchi M. - Chitosan hydrogel as a drug delivery carrier to control angiogenesis. - J. Artif. Organs, 9, 8-16, 2006.
28. Ta H.T., Dass C.R., Dunstan D.E.- Injectable chitosan hydrogels for localised cancer therapy. - J. Control. ReL, 126, 205-216, 2008.
29. Paulsson M., Hagerstrom H., Edsman K. - Rheological studies of the gelation of deacetylated gellan gum (Gelrite) in physiological conditions. - Eur. J. Pharm. Sci., 9, 99-105, 1999.
30. Hornof M.D., Kast C.E., Bernkop-Schnurch A. - In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. - Eur. J. Pharm. Biopharm., 55, 185-190, 2003.
31. Sakloetsakun D., Hombach J., Bernkop-Schnürch A. - In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents. - Biomaterials, 30, 6151-6157, 2009.
32. Bernkop-Schnürch A., Krauland A., Leitner V., Palmberger T. -Thiomers: potential excipients for non-invasive peptide delivery systems. - Eur. J. Pharm. Biopharm., 58, 253-263, 2004.
33. Muranishi S. - Absorption enhancers. - Crit. Rev. Ther. Drug Carrier Syst., 7, 1-33, 1990.
34. Greindl M. - Oral drug delivery: design and in vitro/ in vivo evaluation of novel permeation enhancers and efflux pump inhibitors. - Universtiy of Innsbruck, 2008.
35. Langoth N., Bernkop-Schnürch A., Kurka P. - In vitro evaluation of various buccal permeation enhancing systems for PACAP (pituitary adenylate cyclase-activating polypeptide). - Pharm. Res., 22, 2045-2050, 2005.
36. Werle M. - Natural and synthetic polymers as inhibitors of drug efflux pumps. - Pharm. Res., 25, 500-511, 2008.
37. Hombach J., Hoyer H., Bernkop-Schnürch A. - Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system. - Eur. J. Pharm. Sci., 33, 1-8, 2008.
38. Cordon-Cardo C, O'Brien J., Boccia J., Casals D., Bertino J., Melamed M. - Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. - J. Histochem. Cytochem., 38, 1277-1287, 1990.
39. Varma M., Ashokraj Y., Dey C., Panchagnula R.- P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. - Pharmacol. Res., 48, 347-359, 2003.
40. Föger F., Hoyer H., Kafedjiiski K.,Thaurer M., Bernkop-Schnürch A. - In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein. - Biomaterials, 27, 5855-5860, 2006.
41. Ferté J. - Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. - Eur. J. Biochem., 267, 277-294, 2000.
42. De Smedt S., Demeester J., Hennink W. - Cationic polymer based gene delivery systems. - Pharm. Res., 17, 113-126, 2000.
43. Martien R., Loretz B.,Thaler M., Majzoob S., Bernkop-Schnürch A. - Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery? - J. Biomed. Mater. Res. A, 82, 1-9,2007.
44. Lee D., Zhang W., Shirley S., Kong X., Hellermann G., Lockey R., Mohapatra S. - Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. - Pharm. Res., 24, 157-167, 2007.
45. Guggi D., Krauland A., Bernkop-Schnürch A. - Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin. - J. Control Release, 92, 125-135, 2003.
46. Bernkop-Schnürch A., Kast C., Guggi D. - Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. - J. Control. Rel., 93, 95-103, 2003.
47. Chesnut C.H., Azria M., Silverman S., Engelhardt M., Olson M., Mindeholm L. - Salmon calcitonin: a review of current and future therapeutic indications. - Osteoporos. Int., 19, 479-491, 2008.
48. Schmitz T., Bravo-Osuna I., Vauthier C., Ponchel G., Loretz B., Bernkop-Schnürch A. - Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system. - Biomaterials, 28, 524-531, 2007.
49. Guggi D., Langoth N., Hoffer M., Wirth M., Bernkop-Schnürch A. - Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugate. - Int. J. Pharm., 278, 353-360, 2004.
50. Bernkop-Schnürch A., Hornof M., Kast C. -Tholated polymers: stability of thiol moieties under different storage conditions. - Sci. Pharm., 70, 331-339, 2002.
51. Coupe A., Davis S., Wilding I. - Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. - Pharm. Res., 8, 360-364, 1991.
52. Wawrezinieck A., Péan J., Wüthrich P., Benoit J. - Oral bioavailability and drug/carrier particulate systems. - Med. Sci. (Paris), 24, 659-664, 2008.
53. Albrecht K., Bernkop-Schnürch A. - Thiomers: forms, functions and applications to nanomedicine. - Nanomed., 2 ,41-50, 2007.
54. Bravo-Osuna l., Vauthier C., Farabollini A., Palmieri G., Ponchel G. - Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. - Biomaterials, 28, 2233-2243, 2007.
55. Bravo-Osuna I., Vauthier C., Chacun H., Ponchel G. - Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles. - Eur. J. Pharm. Biopharm., 69, 436-444, 2008.
56. Moghaddam F., Atyabi F., Dinarvand R.- Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMAcore-shell nanoparticles.-Nanomed., 5, 208-215, 2009.
57. Lee D., Shirley S., Lockey R., Mohapatra S. -Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. - Respir. Res., 7, 1-10, 2006.
58. Bernkop-Schnürch A., Weithaler A., Albrecht K., Greimel A. -Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. - Int. J. Pharm., 317, 76-81, 2006.
59. Langer R., Folkman J. - Polymers for the sustained release of proteins and other macromolecules. - Nature, 263, 797-800, 1976.
60. Krauland A., Guggi D., Bernkop-Schnürch A. - Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats. - J. Control Release, 95, 547-555, 2004.
61. Bernkop-Schnürch A., Pinter Y., Guggi D., Kahlbacher H., Schöffmann G., Schuh M., Schmerold I., Del C.M., D'Antonio M., Esposito P., Huck C. - The use of thiolated polymers as carrier matrix in oral peptide delivery - proof of concept. - J. Control. ReI., 106, 26-33, 2005.
62. Föger F.,, Schmitz T., Bernkop-Schnürch A.- In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. - Biomaterials, 27, 4250-4255, 2006.
63. Illum L. - Nasal drug delivery - possibilities, problems and solutions. - J. Control Release, 87, 187-198, 2003.
64. Krauland A., Guggi D., Bernkop-Schnürch A.-Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. - Int. J. Pharm., 307, 270-277, 2006.
65. Veuillez F., Kalia Y., Jacques Y., Deshusses J., Buri P. - Factors and strategies for improving buccal absorption of peptides. - Eur. J. Pharm. Biopharm., 51, 93-109, 2001.
66. Langoth N., Kahlbacher H., Schöffmann G., Schmerold I., Schuh M., Franz S., Kurka P., Bernkop-Schnürch A.-Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system. - Pharm. Res., 23, 573-579, 2006.